05:15 PM EDT, 10/03/2025 (MT Newswires) -- Todd Watanabe, Director, President and Chief Executive Officer, on October 01, 2025, sold 45,000 shares in Arcutis Biotherapeutics ( ARQT ) for $884,649. Following the Form 4 filing with the SEC, Watanabe has control over a total of 1,079,574 common shares of the company, with 846,440 shares held directly and 233,134 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000180106125000006/xslF345X05/wk-form4_1759525359.xml